U.S. markets closed
  • S&P 500

    3,678.43
    +92.81 (+2.59%)
     
  • Dow 30

    29,490.89
    +765.38 (+2.66%)
     
  • Nasdaq

    10,815.43
    +239.82 (+2.27%)
     
  • Russell 2000

    1,708.87
    +44.15 (+2.65%)
     
  • Crude Oil

    83.25
    +3.76 (+4.73%)
     
  • Gold

    1,708.70
    +36.70 (+2.19%)
     
  • Silver

    20.77
    +1.73 (+9.09%)
     
  • EUR/USD

    0.9827
    +0.0026 (+0.27%)
     
  • 10-Yr Bond

    3.6510
    -0.1530 (-4.02%)
     
  • GBP/USD

    1.1320
    +0.0154 (+1.38%)
     
  • USD/JPY

    144.6260
    -0.1030 (-0.07%)
     
  • BTC-USD

    19,534.90
    +281.76 (+1.46%)
     
  • CMC Crypto 200

    443.68
    +8.33 (+1.91%)
     
  • FTSE 100

    6,908.76
    +14.95 (+0.22%)
     
  • Nikkei 225

    26,215.79
    +278.58 (+1.07%)
     

Augmedix Launches New Service, Augmedix Prep, to Significantly Reduce Physician Chart Prep Burden

·3 min read
Augmedix Inc
Augmedix Inc

Allows Physicians to Spend Less Time in the EHR and More Time with Patients

SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation solutions, announces today the launch of Augmedix Prep, a new service that significantly reduces the burden on medical staff from preparing charts prior to a patient visit.

The new service features technology that prepares a patient note structure and content for the physician based on the unique visit type and the patient’s previous medical records. Alleviating this manual task ahead of time, physicians simply review the information prior to seeing the patient, allowing them to enter the visit ready to engage with the patient.

“Augmedix is on a mission to remove the barriers to care that frustrate both physicians and patients,” said Manny Krakaris, Chief Executive Officer of Augmedix. “Augmedix Prep is a significant value-add service that reduces the administrative burden exacerbating clinician burnout.”

Augmedix Prep is designed to address some of the most significant issues facing healthcare providers today, including reducing their workload, which can help mitigate clinician burnout and improve satisfaction, as well as allowing time back to focus on patients.

Augmedix Prep captures valuable information such as patient demographics, medication changes, up-to-date medical history, imaging, labs and diagnostic results, immunization history and past medical, family, and social history.

At its core, chart prep is a time-consuming administrative task that can negatively impact the patient encounter. Augmedix believes that by completing charting work prior to patient encounters, the physician will be better prepared and will offer more time in their schedule for delivering care, resulting in improved patient and provider experience and increasing patient satisfaction.

About Augmedix
Augmedix, Inc. (Nasdaq: AUGX) provides automated medical documentation and data services to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments, and telemedicine nationwide. The company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and performs a suite of related data services. These services relieve physicians of administrative burdens to enable more time for patient care. Augmedix’s proprietary platform uses automatic speech recognition, natural language processing and clinical datasets to capture the ambient visit conversation and generate a structured medical note. The structured medical note data is then used to deliver additional data services. Quality is assured by trained medical documentation specialists. To learn more about Augmedix, visit augmedix.com.

Forward-Looking Statements
This press release contains "forward-looking statements" that involve a number of risks and uncertainties. Such forward-looking statements include, without limitation, statements regarding the intended benefits of Augmedix Prep to healthcare providers. Actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in our most recent Form 10-K filed with the U.S. Securities and Exchange Commission on March 30, 2022 as well as other documents that may be filed by us from time to time with the U.S. Securities and Exchange Commission. The forward-looking statements included in this press release represent our views as of the date of this press release. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Investors:
Caroline Paul
Gilmartin Group
investors@augmedix.com

Media:
Kaila Grafeman
Augmedix
pr@augmedix.com